产品编号：
62-0-78b
产品名称：
ß-Amyloid (1-40)
规格型号：
1mg
生产厂家：
americanpeptide
*
American Peptide公司专注于为药物研发和其他生命科学领域提供高品质的多肽和蛋白质研究产品和服务。公司提供的种类丰富的多肽，定制服务，及按GMP标准生产作为活性药物成分的非专li多肽或定制多肽。公司提供的服务包括工艺开发，扩大生产、分析和工艺验证，稳定性研究，CMC，DMF。
以下目录多肽每个产品类别包括多个产品，如细胞程序化死亡及相关多肽中的Caspase-1底物和抑制剂：
|
产品 |
货号 |
来源 |
规格 |
|
Ac-VAD-CHO |
81-7-02A |
Ac-Val-Ala-Asp-CHO |
1.0 mg |
|
Ac-VAD-CHO |
81-7-02B |
Ac-Val-Ala-Asp-CHO |
5.0 mg |
|
Ac-YVAD-AMC |
81-7-30B |
Ac-Tyr-Val-Ala-Asp-AMC |
5.0 mg |
|
Ac-YVAD-AMC |
81-7-30A |
Ac-Tyr-Val-Ala-Asp-AMC |
1.0 mg |
|
Ac-YVAD-CHO |
81-7-31B |
Ac-Tyr-Val-Ala-Asp-CHO |
5.0 mg |
|
Ac-YVAD-CHO |
81-7-31A |
Ac-Tyr-Val-Ala-Asp-CHO |
1.0 mg |
|
Ac-YVAD-pNA |
81-7-34 |
Ac-Tyr-Val-Ala-Asp-pNA |
1.0 mg |
|
Ac-YVKD-CMK |
81-7-3 |
Ac-Tyr-Val-Ala-Asp-CMK |
0.5 mg |
|
Ac-YVKD-CMK |
81-7-35B |
Ac-Tyr-Val-Ala-Asp-CMK |
1.0 mg |
|
Biotin-YVAD-CHO |
81-7-36A |
Biotin-Tyr-Val-Ala-Asp-CHO |
0.5 mg |
|
Biotin-YVAD-CHO |
81-7-36B |
Biotin-Tyr-Val-Ala-Asp-CHO |
1.0 mg |
|
Calpain Inhibitor Peptide |
81-5-40 |
Asp-Pro-Met-Ser-Ser-Thr-Tyr-Ile-Glu-Glu-Leu-Gly-Lys-Arg-Glu-Val-Thr-Ile-Pro-Pro-Lys-Tyr-Arg-Glu-Leu-Leu-Ala |
0.5 mg |
|
Caspase-1 Inhibitor I, Cell-Permeable |
81-6-36A |
Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Tyr-Val-Ala-Asp-CHO |
0.5 mg |
|
Caspase-1 Inhibitor I, Cell-Permeable |
81-6-36B |
Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Tyr-Val-Ala-Asp-CHO |
1.0 mg |
|
Caspase-1 Inhibitor V |
81-7-06A |
Z-Val-Ala-Asp(OMe)-fluoromethylketone |
0.5 mg |
|
Caspase-1 Inhibitor V |
81-7-06B |
Z-Val-Ala-Asp(OMe)-fluoromethylketone |
1.0 mg |
|
Caspase-3 Subtrate Ac-Asp-Asn-Leu-Asp-AMC |
81-6-45 |
Ac-Asp-Asn-Leu-Asp-AMC |
0.5 mg |
|
Caspase-7 Substrate I, Fluorogenic |
81-7-97A |
Mca-Val-Asp-Gln-Val-Asp-Gly-Trp-Lys(Dnp)-NH2 |
0.5 mg |
|
Caspase-7 Substrate I, Fluorogenic |
81-7-97B |
Mca-Val-Asp-Gln-Val-Asp-Gly-Trp-Lys(Dnp)-NH2 |
1.0 mg |
|
GSK-3β Peptide Inhibitor |
81-6-38A |
Lys-Glu-Ala-Pro-Pro-Ala-Pro-Pro-Gln-Ser(PO3H)-Pro-NH2 |
0.5 mg |
|
GSK-3β Peptide Inhibitor |
81-6-38B |
Lys-Glu-Ala-Pro-Pro-Ala-Pro-Pro-Gln-Ser(PO3H)-Pro-NH2 |
1.0 mg |
|
GSK-3β Peptide Inhibitor, Cell Permeable |
81-6-39A |
Myr-N-Gly-Lys-Glu-Ala-Pro-Pro-Ala-Pro-Pro-Gln-Ser(PO3H)-Pro-NH2 |
0.5 mg |
|
GSK-3β Peptide Inhibitor, Cell Permeable |
81-6-39B |
Myr-N-Gly-Lys-Glu-Ala-Pro-Pro-Ala-Pro-Pro-Gln-Ser(PO3H)-Pro-NH2 |
1.0 mg |
|
IL-1b Converting Enzyme (ICE) Inhibitor IV |
81-7-01 |
Ac-Tyr-Val-Lys-Asp-CHO |
1.0 mg |
|
TNF-a (71-82), human |
81-1-12A |
Ser-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg |
0.5 mg |
|
TNF-a (71-82), human |
81-1-12B |
Ser-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg |
1.0 mg |
|
YVAD-CHO |
81-7-38A |
Tyr-Val-Ala-Asp-CHO |
1.0 mg |
|
YVAD-CHO |
81-7-38B |
Tyr-Val-Ala-Asp-CHO |
5.0 mg |
|
Z-Val-Ala-Asp-AMC |
81-7-85 |
Z-Val-Ala-Asp-AMC |
1.0 mg |
部分淀粉样蛋白和相关多肽产品：
|
ß-Amyloid (1-11) |
62-0-10A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu |
0.5 mg |
|
ß-Amyloid (1-11) |
62-0-10B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu |
1.0 mg |
|
ß-Amyloid (1-16), human |
62-0-36A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys |
0.5 mg |
|
ß-Amyloid (1-16), human |
62-0-36B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys |
1.0 mg |
|
ß-Amyloid (1-28) |
62-0-74B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys |
1.0 mg |
|
ß-Amyloid (1-28) |
62-0-74A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys |
0.5 mg |
|
ß-Amyloid (1-38) |
62-0-76A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly |
0.5 mg |
|
ß-Amyloid (1-38) |
62-0-76B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly |
1.0 mg |
|
ß-Amyloid (1-38), mouse, rat |
62-1-00A |
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly |
0.5 mg |
|
ß-Amyloid (1-38), mouse, rat |
62-1-00B |
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly |
1.0 mg |
|
ß-Amyloid (1-40) |
62-0-78A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
0.5 mg |
|
ß-Amyloid (1-40) |
62-0-78B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
1.0 mg |
|
ß-Amyloid (10-20) |
62-0-20A |
Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe |
0.5 mg |
|
ß-Amyloid (10-20) |
62-0-20B |
Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe |
1.0 mg |
|
ß-Amyloid (12-28) |
62-0-73A |
Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys |
0.5 mg |
|
ß-Amyloid (12-28) |
62-0-73B |
Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys |
1.0 mg |
|
ß-Amyloid (22-35) |
62-0-3 |
Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met |
0.5 mg |
|
ß-Amyloid (22-35) |
62-0-35B |
Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met |
1.0 mg |
|
ß-Amyloid (25-35) |
62-0-72A |
Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met |
0.5 mg |
|
ß-Amyloid (25-35) |
62-0-72B |
Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met |
1.0 mg |
|
ß-Amyloid (31-35) |
62-0-31A |
Ile-Ile-Gly-Leu-Met |
1.0 mg |
|
ß-Amyloid (31-35) |
62-0-31B |
Ile-Ile-Gly-Leu-Met |
5.0 mg |
|
ß-Amyloid (32-35) |
62-0-12 |
Ile-Gly-Leu-Met |
1.0 mg |
|
ß-Amyloid (35-25) |
62-0-33A |
Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly |
0.5 mg |
|
ß-Amyloid (35-25) |
62-0-33B |
Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly |
1.0 mg |
|
ß-Amyloid (40-1) |
62-0-77 |
Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp |
0.1 mg |
|
ß-Amyloid / A4 Protein Precursor (APP) (96-110), analog |
62-1-1 |
Ac-Asn-Trp-Cys-Lys-Arg-Gly-Arg-Lys-Gln-Cys-Lys-Thr-His-Pro-His-NH2 |
0.5 mg |
|
ß-Amyloid / A4 Protein Precursor (APP) (96-110), analog |
62-1-15B |
Ac-Asn-Trp-Cys-Lys-Arg-Gly-Arg-Lys-Gln-Cys-Lys-Thr-His-Pro-His-NH2 |
1.0 mg |
|
ß-Amyloid / A4 Protein Precusor (APP) (319-335) |
62-5-10A |
Ala-Lys-Glu-Arg-Leu-Glu-Ala-Lys-His-Arg-Glu-Arg-Met-Ser-Gln-Val-Met |
0.5 mg |
|
ß-Amyloid / A4 Protein Precusor (APP) (319-335) |
62-5-10B |
Ala-Lys-Glu-Arg-Leu-Glu-Ala-Lys-His-Arg-Glu-Arg-Met-Ser-Gln-Val-Met |
1.0 mg |
|
ßAmyloid BRI Peptide (1-34) |
62-0-92B |
Glp-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Ser-Arg-Thr-Val-Lys-Lys-Asn-Ile-Ile-Glu-Glu-Asn |
1.0 mg |
|
ßAmyloid BRI Peptide (1-34) |
62-0-92A |
Glp-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Ser-Arg-Thr-Val-Lys-Lys-Asn-Ile-Ile-Glu-Glu-Asn |
0.5 mg |
|
β-Amyloids (1-42), FAM – labeled |
62-1-01 |
5FAM-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala |
0.1 mg |
|
β-Amyloid (1-40), amide |
62-0-6 |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-NH2 |
0.5 mg |
|
β-Amyloid (1-40), amide |
62-0-65B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-NH2 |
1.0 mg |
|
β-Amyloid (1-40), rat |
62-0-86A |
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
0.5 mg |
|
β-Amyloid (1-40), rat |
62-0-86B |
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
1.0 mg |
|
β-Amyloid (1-42) |
62-0-80A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala |
0.5 mg |
|
β-Amyloid (1-42) |
62-0-80B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala |
1.0 mg |
|
β-Amyloid (1-43) |
62-0-83A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr |
0.5 mg |
|
β-Amyloid (1-43) |
62-0-83B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr |
1.0 mg |
|
β-Amyloid (17-28) |
62-0-13A |
Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys |
0.5 mg |
|
β-Amyloid (17-28) |
62-0-13B |
Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys |
1.0 mg |
|
β-Amyloid (33-42) |
62-0-22A |
Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala |
0.5 mg |
|
β-Amyloid (33-42) |
62-0-22B |
Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala |
1.0 mg |
|
(Glp3) b-Amyloid (3-42) |
62-0-21A |
Glp-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala |
0.5 mg |
|
(Glp3) b-Amyloid (3-42) |
62-0-21B |
Glp-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala |
1.0 mg |
|
Ac-Leu-Pro-Phe-Phe-Asp-NH2 |
62-0-18A |
Ac-Leu-Pro-Phe-Phe-Asp-NH2 |
0.5 mg |
|
Ac-Leu-Pro-Phe-Phe-Asp-NH2 |
62-0-18B |
Ac-Leu-Pro-Phe-Phe-Asp-NH2 |
1.0 mg |
|
Ac-Lys-N-Me-Leu-Val-N-Me-Phe-Phe-NH2 |
62-0-19A |
Ac-Lys-(NMe)Leu-Val-(NMe)Phe-Phe-NH2 |
0.5 mg |
|
Ac-Lys-N-Me-Leu-Val-N-Me-Phe-Phe-NH2 |
62-0-19B |
Ac-Lys-(NMe)Leu-Val-(NMe)Phe-Phe-NH2 |
1.0 mg |
|
Amyloid β-Protein (1-15) |
62-1-04A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln |
1.0 mg |
|
Amyloid β-Protein (1-15) |
62-1-04B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln |
5.0 mg |
|
Amyloid β-Protein (10-35) Trifluoroacetate |
62-1-03A |
Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met |
1.0 mg |
|
Amyloid β-Protein (10-35) Trifluoroacetate |
62-1-03B |
Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met |
5.0 mg |
|
Amyloid β-Protein (6-20) |
62-1-02B |
His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe |
5.0 mg |
|
Amyloid β-Protein (6-20) |
62-1-02A |
His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe |
1.0 mg |
|
Amyloid BRI Precursor277 (89-106) |
62-0-02A |
Cys-Gly-Ile-Lys-Tyr-Ile-Lys-Asp-Asp-Val-Ile-Leu-Asn-Glu-Pro-Ser-Ala-Asp |
0.5 mg |
|
Amyloid BRI Precursor277 (89-106) |
62-0-02B |
Cys-Gly-Ile-Lys-Tyr-Ile-Lys-Asp-Asp-Val-Ile-Leu-Asn-Glu-Pro-Ser-Ala-Asp |
1.0 mg |
|
Amyloid Dan Protein (1-34) |
62-0-04A |
Glp-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Phe-Asn-Leu-Phe-Leu-Asn-Ser-Gln-Glu-Lys-His-Tyr |
0.5 mg |
|
Amyloid Dan Protein (1-34) |
62-0-04B |
Glp-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Phe-Asn-Leu-Phe-Leu-Asn-Ser-Gln-Glu-Lys-His-Tyr |
1.0 mg |
|
Amyloid Precursor C-Terminal Peptide |
62-0-15B |
Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn |
1.0 mg |
|
Amyloid Precursor C-Terminal Peptide |
62-0-1 |
Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn |
0.5 mg |
|
Amyloid Precursor Frameshift Mutant C-Terminal Peptide |
81-3-10A |
Arg-Gly-Arg-Thr-Ser-Ser-Lys-Glu-Leu-Ala |
0.5 mg |
|
Amyloid Precursor Frameshift Mutant C-Terminal Peptide |
81-3-10B |
Arg-Gly-Arg-Thr-Ser-Ser-Lys-Glu-Leu-Ala |
1.0 mg |
|
Amyloid Precursor N-Terminal Peptide |
62-0-14A |
His-Met-Asn-Val-Gln-Asn-Gly-Lys-Trp-Asp-Ser-Asp-Pro-Ser-Gly-Thr-Lys-Thr-Cys-Ile |
0.5 mg |
|
Amyloid Precursor N-Terminal Peptide |
62-0-14B |
His-Met-Asn-Val-Gln-Asn-Gly-Lys-Trp-Asp-Ser-Asp-Pro-Ser-Gly-Thr-Lys-Thr-Cys-Ile |
1.0 mg |
|
b-Amyloid (10-35), amide |
62-0-16A |
Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-NH2 |
0.5 mg |
|
b-Amyloid (10-35), amide |
62-0-16B |
Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-NH2 |
1.0 mg |
|
b-Amyloid (17-40) |
62-0-8 |
Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
0.5 mg |
|
b-Amyloid (17-40) |
62-0-85B |
Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
1.0 mg |
|
b-Amyloid (42-1) |
62-0-81 |
Ala-Ile-Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp |
0.1 mg |
|
Beta-Amyloid Peptide (1-42), mouse, rat |
62-0-84A |
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala |
0.5 mg |
|
Beta-Amyloid Peptide (1-42), mouse, rat |
62-0-84B |
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala |
1.0 mg |
|
Beta-Sheet Breaker Peptide iAβ5 |
62-0-06 |
Leu-Pro-Phe-Phe-Asp |
1.0 mg |
|
Biotinylated-β-Amyloid (1-42) |
62-0-51A |
Biotin-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala |
0.5 mg |
|
Biotinylated-β-Amyloid (1-42) |
62-0-51B |
Biotin-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala |
1.0 mg |
|
Non-ß-Amyloid Component of Alzheimer’s Disease (NAC) |
62-5-25 |
Glu-Gln-Val-Thr-Asn-Val-Gly-Gly-Ala-Val-Val-Thr-Gly-Val-Thr-Ala-Val-Ala-Gln-Lys-Thr-Val-Glu-Gly-Ala-Gly-Ser-Ile-Ala-Ala-Ala-Thr-Gly-Phe-Val |
0.1 mg |
|
Prion Protein (118-135), human |
62-0-00A |
Ala-Gly-Ala-Val-Val-Gly-Gly-Leu-Gly-Gly-Tyr-Met-Leu-Gly-Ser-Ala-Met-Ser |
0.5 mg |
|
Prion Protein (118-135), human |
62-0-00B |
Ala-Gly-Ala-Val-Val-Gly-Gly-Leu-Gly-Gly-Tyr-Met-Leu-Gly-Ser-Ala-Met-Ser |
1.0 mg |
|
[Arg13] b-Amyloid (1-40) |
62-0-27A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
0.5 mg |
|
[Arg13] b-Amyloid (1-40) |
62-0-27B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
1.0 mg |
|
[Arg22] b-Amyloid (1-40) |
62-0-87B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Arg-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
1.0 mg |
|
[Arg22] b-Amyloid (1-40) |
62-0-87A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Arg-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
0.5 mg |
|
[Asp22] b-Amyloid (1-40) |
62-0-88B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Asp-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
1.0 mg |
|
[Asp22] b-Amyloid (1-40) |
62-0-88A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Asp-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
0.5 mg |
|
[Cys] b-Amyloid (1-40) |
62-0-23A |
Cys-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
0.5 mg |
|
[Cys] b-Amyloid (1-40) |
62-0-23B |
Cys-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
1.0 mg |
|
[Gln11] ß-Amyloid (1-16) |
62-0-70A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys |
0.5 mg |
|
[Gln11] ß-Amyloid (1-16) |
62-0-70B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys |
1.0 mg |
|
[Gln11] ß-Amyloid (1-28) |
62-0-7 |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys |
0.5 mg |
|
[Gln11] ß-Amyloid (1-28) |
62-0-75B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys |
1.0 mg |
|
[Gln11] b-Amyloid (1-40) |
62-0-79A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
0.5 mg |
|
[Gln11] b-Amyloid (1-40) |
62-0-79B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
1.0 mg |
|
[Gln22] ßAmyloid (1-40) |
62-0-89A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gln-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
0.5 mg |
|
[Gln22] ßAmyloid (1-40) |
62-0-89B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gln-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
1.0 mg |
|
[Gly21] β-Amyloid (1-40) |
62-0-61A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Gly-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
0.5 mg |
|
[Gly21] β-Amyloid (1-40) |
62-0-61B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Gly-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
1.0 mg |
|
[Gly22] β-Amyloid (1-40) |
62-0-24A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
0.5 mg |
|
[Gly22] β-Amyloid (1-40) |
62-0-24B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
1.0 mg |
|
[Lys22] b-Amyloid (1-40) |
62-0-91B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Lys-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
1.0 mg |
|
[Lys22] b-Amyloid (1-40) |
62-0-91A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Lys-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
0.5 mg |
|
[Nle35] b-Amyloid (1-40) |
62-0-26A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Nle-Val-Gly-Gly-Val-Val |
0.5 mg |
|
[Nle35] b-Amyloid (1-40) |
62-0-26B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Nle-Val-Gly-Gly-Val-Val |
1.0 mg |
|
[Phe10] b-Amyloid (1-40) |
62-0-2 |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Phe-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
0.5 mg |
|
[Phe10] b-Amyloid (1-40) |
62-0-25B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Phe-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
1.0 mg |
|
ß-Amyloid (1-24) |
62-0-11A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val |
0.5 mg |
|
ß-Amyloid (1-24) |
62-0-11B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val |
1.0 mg |
|
ß-Amyloid (1-46) |
62-0-59A |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr-Val-Ile-Val |
0.5 mg |
|
ß-Amyloid (1-46) |
62-0-59B |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr-Val-Ile-Val |
1.0 mg |
目录多肽：
A
血管紧张素转换酶抑制剂ACE Inhibitors
激脂激素 Adipokinetic Hormones
促肾上腺皮质激素（ ACTH ） Adrenocorticotropic Hormones (ACTH)
肾上腺髓质素 Adrenomedullins
刺鼠相关肽 Agouti Related Peptides
咽侧体抑制素[抑制保幼激素的分泌] Allatostatins
支链淀粉Amylins
淀粉样蛋白＆相关肽 Amyloids & Related Peptides
血管紧张素 Angiotensins
抗炎肽 Anti-Inflammatory Peptides
抗生素肽 Antibiotic Peptides
抗菌肽 Antimicrobial Peptides
抗氧化肽 Antioxidant Peptides
Apelin的肽 Apelin Peptides
细胞凋亡及相关肽Apoptosis & Related Peptides
心房利钠肽 Atrial Natriuretic Peptides
B
囊细胞肽 Bag Cell Peptides
大内皮素及类似物 Big Endothelin & Analogs
蛙皮素 Bombesins
骨钙蛋白 Bone Gla Proteins
缓激肽 Bradykinins
脑利钠肽（ BNP）Brain Natriuretic Peptides (BNP)
C
C-肽 C-Peptides
C-型利钠肽 C-Type Natriuretic Peptides
降钙素及降钙素基因相关肽 Calcitonin & Calcitonin Gene Related Peptides (CGRP).
钙蛋白酶抑制剂 Calpain Inhibitors
酪啡肽Casomorphins
组织蛋白酶及相关肽 Cathepsins & Related Peptides
氯甲基酮 Chloromethylketones
缩胆囊素（胆囊收缩素）Cholecystokinins (CCK)
芋螺毒素及其他毒素Conotoxins & Other Toxins
促肾上腺皮质激素释放因子Corticotropin Releasing Factors
皮质醇稳定蛋白 Cortistatins
D
防御素 Defensins
强啡肽 Dynorphins
E
内吗啡肽Endomorphins
内啡肽 Endorphins
内皮抑素 Endostatins
内皮素-1及类似物Endothelin-1 & Analogs
内皮素-2 ，内皮素-3及类似物Endothelin-2, Endothelin-3 & Analogs
内皮素及相关肽Endothelins & Related Peptides
脑啡肽Enkephalins
唾液素 Exendins
F
纤连蛋白和细胞外基质相关多肽 Fibronectin and Extra Cellular Matrix Related Pept…
FMRF及类似物 FMRF & Analogs
G
甘丙素 Galanins
抑胃肽 Gastric Inhibitory Peptides
胃泌素 Gastrins
饥饿激素Ghrelins
胰高血糖素和胰高血糖素样肽 Glucagons and Glucagon-Like Peptides
促性腺激素释放激素相关肽 GnRH Associated Peptides
生长因子片段 Growth Factor Fragments
生长激素和生长激素释放因子 Growth Hormone & Growth Hormone Releasing Factors（GHRF）
GTP结合蛋白片段 GTP-Binding Protein Fragments
鸟苷素Guanylins
I
昆虫神经肽 Insect-Neuropeptides
L
层粘连蛋白肽 Laminin Peptides
瘦素肽片段 Leptin Fragment Peptides
白细胞激肽及类似物 Leucokinin & Analogs
促黄体激素释放因子及类似物 LH-RH & Analogs
M
肥大细胞脱颗粒肽 Mast Cell Degranulating Peptides
黑色素浓集激素（ MCH ）Melanin Concentrating Hormone (MCH)
黑素细胞刺激素（ MSH ）Melanocyte Stimulating Hormones (MSH)
黑色素瘤肽 Melanoma peptides
杂项肽 Miscellaneous Peptides
基质金属蛋白酶基质 MMP Substrates
Motilins
髓磷脂少突胶质细胞糖蛋白（MOG ）肽 Myelin Oligodendrocyte Glycoprotein (MOG) Peptide
N
神经内分泌调节肽 Neuroendocrine Regulatory Peptides
神经激肽 Neurokinins
神经调节肽 Neuromedins
神经肽W- 23及类似物Neuropeptide W-23 and Analog
神经肽Y及类似物 Neuropeptide Y & Analogs
神经肽及相关肽 Neuropeptides & Related Peptides
神经降压素Neurotensins
O
阿片类药物相关肽Opioid Related Peptides
食欲素 Orexins
催产素Oxytocins
P
胰抑素及相关肽 Pancreastatin & Related Peptides
胰多肽 Pancreatic Polypeptides
胰多肽及相关肽 Pancreatic Polypeptides & Related Peptides
甲状旁腺激素及类似物（ PTH ）Parathyroid Hormone & Analogs (PTH)
肽YY Peptides YY
肽酶底物Petidase Substrates
鬼笔（毒）环肽Phalloidins
垂体腺苷酸环化酶激活肽 Pituitary Adenylate Cyclase Activating Peptides (PACAP)
催乳素释放肽 Prolactin Releasing Peptide
蛋白酶抑制剂 Protease Inhibitor
蛋白激酶及相关肽 Protein Kinase and Related Peptides
R
肾素底物及抑制剂 Renin Substrates & Inhibitors
S
毒素肽 Sarafotoxins
分泌素 Secretins
信号转导试剂 Signal Transduction Reagents
生长抑素 (促生长素抑制素)及类似物 Somatostatins & Analogs
顶压素相关肽 Stresscopin Related Peptides
P物质及相关肽 Substance P & Related Peptides
底物和酶抑制剂Substrate & Enzyme Inhibitors
T
TAT蛋白 TAT Proteins
血凝素相关&（蛋白酶激活受体）AP多肽 Thrombin Related & (PAR) AP peptides
血小板反应蛋白 Thrombospondin
血小板反应蛋白-I（ TS-I ）细胞结合区 Thrombospondin-I (TS-I) Cell Binding Domain
胸腺生成素和胸腺素肽Thymopoietin & Thymosin Peptides
促甲状腺激素释放激素（TRH） Thyrotropin-Releasing Hormones (TRH)
U
尿皮素 Urocortins
尿紧张素 Urotensins
V
血管活性肠肽 Vasoactive Intestinal Peptides (VIP)
血管紧张素 Vasopressins
病毒相关多肽 Virus Related Peptides
非专li多肽：
人胰高血糖素 Glucagon, human
亮丙瑞林 Leuprolide
奥曲肽 Octreotide
夫替瑞林[垂体激素释放兴奋药] Fertirelin
鲑鱼降钙素Calcitonin, salmon
人/大鼠促肾上腺皮质激素释放因子 Corticotropin Releasing Factor, human, rat
人脑利钠肽 Brain Natriuretic Peptide, human
胸腺五肽（TP-5） Thymopentin (TP-5)
促肾上腺皮质激素（ACTH） corticotropin (ACTH)
依降钙素Elcatonin
曲普瑞林[抗肿瘤药] 曲普瑞林 Triptorelin
布舍瑞林[促黄体素释放激素]Buserelin
胸腺素α-1 Thymosin a-1
生长抑素14 Somatostatin 14
唾液素（9-39）Exendin (9-39)